Clinical Trial Update: Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial is evaluating the combination of near-infrared light therapy with lecanemab for mild Alzheimer's disease, and the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lecanemab (lecanemab)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Alzheimer Disease | EARLY_Phase 1 | Status: RECRUITING